Lithiasis and risk factors

Urologia Internationalis

Volumn 79, Issue SUPPL. 1, 2007, Pages 8-15

  Ferrari, P ^a   Piazza, R ^a   Ghidini, N ^a   Bisi, M ^a   Galizia, G ^a   Ferrari, G ^a  

^a HESPERIA HOSPITAL   (Italy)

Author keywords

Nephrolithiasis; Stone diseases, risk factors; Urolithiasis

Indexed keywords

CALCIUM CARBONATE; CARBONATE DEHYDRATASE INHIBITOR; CEFTRIAXONE; COLECALCIFEROL; INDINAVIR; MINERAL; PENTAERYTHRITYL TETRANITRATE; PROTEINASE INHIBITOR; SULFADIAZINE; TOPIRAMATE; TRIAMTERENE; WATER;

ARTICLE; BODY WEIGHT; CLINICAL FEATURE; COMORBIDITY; COST BENEFIT ANALYSIS; DEMOGRAPHY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ECONOMIC ASPECT; ENVIRONMENTAL FACTOR; FLUID INTAKE; GEOGRAPHY; HEALTH SERVICE; HEREDITY; HUMAN; HYPERTENSION; INCIDENCE; LIFESTYLE MODIFICATION; MALABSORPTION; NEPHROLITHIASIS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STOMACH BYPASS; UROLITHIASIS;

AGE FACTORS; BODY WEIGHT; CLIMATE; COMORBIDITY; DIET; DRINKING; DRUG THERAPY; GASTRIC BYPASS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LIFE STYLE; NEPHROLITHIASIS; OBESITY; RISK FACTORS; SEX FACTORS; UROLITHIASIS;

EID: 34548209625     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104435     Document Type: Article

References (102)

1. Yoshida O, Okada Y: Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int 1990;45:104-107.
2. Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, Pisani E: Increase in the prevalence of symptomatic upper urinary stones during the last ten years. Eur Urol 2000;37:23-25.
3. Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P: Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 2003;44:709-713.
4. Chandoke PS: When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol 2002;168:937-940.
5. Saigal CS, Joice G, Timilsina AR: Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int 2005;68:808-114.
6. Fetter TL, Zimskind PD, Graham RH, Brodie DE: Statistical analysis of patients with ureteral calculi. JAMA 1963;186:21-23.
7. Scott R, Freeland R, Mowat W: The prevalence the prevalence of calcified upper urinary tract stone disease in random population - Cumberland health survey. Br J Urol 1977;49:589-595.
8. Ljunghall S: Renal stone disease. Studies on epidemiology and calcium metabolism. Scand J Urol Nephrol 1977;41:1-96.
9. Robertson WG, Peacock M, Baker M: Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. Br J Urol 1983;55:595-598.
10. Sutherland JW, Parks JH, Coe FL: Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab 1985;11:267-269.
11. Ljungghall S, Danielsno BG: A prospective study of renal stone recurrence. Br J Urol 1984;56:122-124.
12. Evans K, Costabile RA: Time to development of symptomatic urinary calculi in a high risk environment. J Urol 2005;173:858-861.
13. Sierakowsky R, Finlayson B, Landes RR, Finlayson CD, Sierakowsky N: The frequency of urolithiasis in hospital discharge diagnoses in the United States. Invest Urol 1978;15:438-441.
14. Strohmaier WL, Hormann M: Economic aspect of urolithiasis and metaphylaxis in Germany; in Rodgers AL, Hibbert BE, Hess B, Khan SR, Preminger GM (eds): Urolithiasis. Cape Town, 2000, vol 1, pp 406-409.
15. Robertson WG: Is prevention of stone recurrence financially worthwhile? Urol Res 2006;34:157-161.
16. Ljunghall S, Danielson B, Fellstrom B, Holmgren K, Johansson G, Wikstrom B: Family history of renal stones in recurrent stone patients. Br J Urol 1985;57:370.
17. Curhan GC, Willett WC, Knight EL, Stampfer MJ: Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med 2004;164:885.
18. Resnik M, Pridgen DB, Goodman HO: Genetic predisposition to formation of calcium oxalate renal lithiasis. N Engl J Med 1968;278:1313-1318.
19. Monga M, Macias B, Groppo E, Hargens A: Genetic heritability of urinary stone risk in identical twins. J Urol 2006;175:2125-2128.
20. Nishijima S, Sugaya K, Naito A, Morozumi M, Hatano Togawa Y: Association of vitamin D receptor gene polymorphism with urolithiasis. J Urol 2002;167:2188-2191.
21. Morrison NA, Qi JC, Tokita A: Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-287.
22. Habuchi T, Suzuki T, Sasaki R: Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res 2000;60:305-308.
23. Lundin A, Soderkvist P, Eriksson B: Association of breast cancer progression with a vitamin D receptor gene. Cancer Res 1999;59:2332-2334.
24. Gunes S, Bilen CY, Kara N, Asci R, Bagci H, Yilmaz AF: Vitamin D receptor gene polymorphism in patients with urolithiasis. Urol Res 2006;34:47-52.
25. Baggio B, Gambaro G, Marchini F, Cicerello E, Tenconi R, Clementi M, Borsatti A: An inheritable anomaly of red-cell oxalate transport in 'primary' calcium nephrolithiasis correctable with diuretics. N Engl J Med 1986;314:599-604.
26. Baggio B, Plebani M, Gambero G: Pathogenesis of idiopathic calcium nephrolithiasis: update 1997. Crit Rev Clin Lab Sci 1998;35:153-187.
27. Hirayama H, Ikegami K, Shimonura T: The possible role of prostaglandins E2 in urinary stone formation. J Urol 1988;139;451-459.
28. Henriquez-La Roche C, Rodriguez-Iturbe B, Parra G: Increased urinary excretion of Prostaglandin E2 in patients with idiopathic hypercalciuria is a primary phenomenon. Clin Sci 1992;83:75-80.
29. Gambaro G, Petrarulo M, Nardellotto A, Marangella M, Baggio B: Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis. Kidney Int 1995;48:1549-1552.
30. Baggio B, Gambaro G: Abnormal arachidonic acid content of membrane phospholipids - the unifying hypothesis for the genesis of hypercalciuria and hyperoxaluria in idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 1999;14:553-555.
31. Baggio B, Budakovic A, Nassuato MA, Vezzoli G, Manzato E, Luisetto G, Zaninotto M: Plasma phospholipids arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int 2000;58:1278-1284.
32. Baggio B, Budakovic A: Fatty acids and idiopathic calcium nephrolithiasis. Urol Int 2005;75;97-101.
33. Baggio B: Fatty acids, calcium and bone metabolism. J Nephrol 2002;15:601-604.
34. Liao RR, Richardson KE: The metabolism of oxalate precursor in isolated perfused rat livers. Arch Biochem Biophys 1972;153;438-448.
35. Finlayson B: Renal lithiasis in review. Urol Clin North Am 1974;1:181-212.
36. Welshman SG, McGeown MG: The relationship of urinary cations, calcium, magnesium, sodium and potassium, in patients with renal calculi. Br J Urol 1975;47:237-242.
37. Robertson WG, Hughes H: Epidemiology of urinary stone disease in Saudi Arabia. Urolithiasis 1994;54:453-455.
38. Ramello A, Vitale C, Marangella M: Epidemiology of nephrolithiasis. J Nephrol 2000;13(suppl):S45-S50.
39. Schwille PO, Herrmann U: Environmental factors in the pathophysiology of recurrent idiopathic calcium nephrolithiasis (RCU), with emphasis on nutrition. Urol Res 1992;20;72-83.
40. Alhadramy MS: Seasonal variation of urinary stone colic in Arabia. J Pak Med Assoc 1997;47:184-281.
41. Prince CL, Scardino PL, Wolan TC: The effect of temperature, humidity, and dehydration on the formation of renal calculi. J Urol 1956;75:209-215.
42. Sierakowsky R, Finlayson B, Landes R: Stone incidence as related to water hardness in different geographical regions of the United States. Urol Res 1979;7:157-160.
43. Churchill DN, Maloney CM, Bear J: Urolithiasis: a study of drinking water hardness and genetic factors. J Chronic Dis 1980;33 727-731.
44. Caudrella R, Rizzoli E, Buffa A: Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis J Urol 1998;159:658-663.
45. Bellizzi V, De Nicola L, Minutolo R: Effect of water hardness on urinary risk factor for kidney stones in patients with idiopathic nephrolithiasis. Nephron 199;81:66-70.
46. Pak CYC, Resnick MI, Preminger GM: Ethnic and geographic diversity of stone disease. Urology 1997;50:504-507.
47. Curhan GC: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-838.
48. Borghi L, Meschi T, Guerra A, Novarini A: Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis. J Urol 1996;155:839-843.
49. Robertson WG, Heyburn PJ, Peacock M: The effect of high protein intake on the risk of calcium stone formation in the urinary tract. Clin Sci 1979;57:285-288.
50. Brockis JG, Levitt AJ, Cruthers SM: The effect of vegetable and animal protein diets on calcium, urate an oxalate excretion. Br J Urol 1982;54:590-593.
51. Fellstrom B, Danielson BG, Karlstrom B: Urinary composition and supersaturation on a high protein diet; in Buccianti G (ed): Risk Profiles in Clinical Nephrology. Contrib Nephrol. Basel, Karger, 1984, vol 37, pp 27-30.
52. Nguyen QV, Kalin A, Drouve S: Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone former. Kidney Int 2001;59:2273-2281.
53. Reddy ST, Wang CY, Sakhaee K, Brinkley L, Pak CY: Effect of low-carbohydrate high protein-diet diets on acid-base balance, stone forming propensity, and calcium metabolism. Am J Kidney Dis 2002;40:265-274.
54. Schuette SA, Zemel MB, Linkswiler HM: Studies on the mechanism of protein-induced hypercalciuria in older men and women. J Nutr 1980;110:305-315.
55. Massey LK, Kynast-Gales SA: Diet with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones. J Am Diet Assoc 2001;101:326-331.
56. Schuette SA, Hegsted M, Zemel MB, Linkswiler HM: Renal acid, urinary cyclic AMP, and hydroxyproline excretion as affected by level of protein, sulfur amino acid and phosphorus intake. J Nutr 1981;111:2106-2116.
57. Brandle E, Hesse A, Hautman RE: Effect of protein on renal excretion of lithogenic substances and glomerular filtration rate-new pathophysiological aspects for the lithogenic action of dietary protein; in Rao PN, Kavanagh JR, Tiselius HG (eds): Urolithiasis Consensus and Controversies. Manchester, University Hospital, 1995, p 265.
58. Giannini S, Nobile M, Sartori L, Carbonare LD, Ciuffreda M, Corrò P, D'Angelo A, Calò L, Crepaldi G: Acute effects of moderate dietary protein restriction in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Am J Clin Nutr 1999;69:267-271.
59. Hess B, Ackerman D, Essig M, Takkinen R, Jaeger P: Renal mass and serum calcitriol in male idiopathic calcium renal stone former: role of protein intake. J Clin Endocrinol Metab 1995;80:1916-1921.
60. Baggio B, Budakovic A, Priante G, Gambaro G, Manzato E, Khan S: Dietary fatty supplementation modulates the urinary excretion of calcium and oxalate in the rat. Insight into calcium lithogenesis. Nephron 2002;91:486-491.
61. Buck AC, Davies RL, Harrison T: The protective role of eicosapentaenoic acid (EPA) in the pathogenesis of urolithiasis. J Urol 1991;146:188-194.
62. Bleich HL, Moore MJ, Lemann J Jr, Adams ND, Gary RW: Urinary calcium excretion in human beings. N Engl J Med 1979;301:535-541.
63. Vahlensiek W: The importance of diet in urinary stones. Urol Res 1986;14:283-288.
64. Robertson WG, Peacock M: The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 1980;26:105-110.
65. Robertson WG: Mild hyperoxaluria: a critical review and future outlook; in Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A (eds): Kidney Stones. 8th European Symposium on Urolithiasis. Cosenza, Editoriale Bios, 1999, pp 33-42.
66. Bataille P, Charransol G, Gregoire I: Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones. J Urol 1983;130:218-223.
67. Kok DJ, Iestra JA, Doorenbos CJ, Papapoulos SE: The effects of dietary excess in animal protein and in sodium on the composition and the cristallization kinetics of calcium oxalate monohydrate in urines of healthy men. J Clin Endocrinol Metab 1990;4:861-867.
68. Sakhaee K, Harvey JA, Padalino PK: The role of salt abuse on the risk for kidney stone formation. J Urol 1993;150:310-312.
69. Devine A, Criddle RA, Dick IM, Kerr DA, Prince RL: Longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr 1995;62:740-745.
70. Lemann J Jr, Piering WF, Lennon EJ: Possible role of carbohydrate-induced calciuria in calcium oxalate kidney stone formation. N Engl J Med 1969;280:232-237.
71. Wood RJ, Gerhardt A, Rosenberg IH: Effects of glucose and glucose polymers on calcium absorption in healthy subjects. Am J Clin Nutr 1987;46:699-701.
72. Nguyen NU, Dumoulin G, Wolf PJ, Bourderont D, Berthelay S: Urinary calcium and oxalate excretion in response to oral glucose load in man. Horm Metab Res 1986;18:869-870.
73. Modlin M: Urinary phosphorylated inositols and renal stone. Lancet 1980;22:1113-1114.
74. Siener R, Glatz S, Nicolay C, Hesse A: The role of overweight and obesity in calcium oxalate stone formation. Obes Res 2004;12:106-113.
75. Lemann J Jr, Pleuss JA, Worcester EM, Hornick L, Schrab D, Hoffmann RG: Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 1996;49:200-208.
76. Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE, Leslie SW: Impact of body weight on urinary electrolytes in urinary stone formers. Urology 2000;55:825-830.
77. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY: Association of urinary pH with body weight in nephrolithiasis. Kidney Int 2004;65:1422-1425.
78. Daudon M, Lacour B, Junger P: Influence of body size on urinary stone composition in men and women. Urol Res 2006;34:193-199.
79. Lieske JC, de la Vega LS, Gettman MT, Siezak JM, Bergstralh EJ, Melton LJ 3rd, Leibson CL: Diabetes mellitus and the risk of urinary tract stones: A population based case-control study. Am J Kidney Dis 2006;48:897-904.
80. Daudon M, Traxer O, Conort P, Lacour B, Jungers P: Type 2 diabetes increases the risk or uric acid stones. J Am Soc Nephrol 2006;17:2026-2033.
81. Timio F, Kerry SM, Anson KM, Eastwood JB, Cappuccio FP: Calcium urolithiasis, blood pressure and salt intake. Blood Press 2003;12:122-127.
82. Hall WD, Pettinger M, Oberman A, Watts NB, Johnson KC, Paskett ED, Limacher MC, Hays J: Risk factors for kidney stones in older women in the southern United States. Am J Med Sci 2001;322:12-18.
83. Gillen DL, Coe FL; Worcester EM: Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis 2005;46:263-269.
84. Cupisti A, Meola M, D'Alessandro C, Bernabini G, Pasquali E, Carpi A, Barsotti G: Insulin resistance and low urinary citrate excretion in calcium stone formers. Biomed Pharmacother 2007;61:86-90.
85. Pieres Ayala E, Grases Freixedas F, Costa Bauza A, Ramis Barcelo M, Piza Reus P, Ozonas Moragues M: Papillary and cavitary monohydrate calcium oxalate lithiasis: comparative study of etiological factors (in Spanish). Arch Esp Urol 2006;59:147-154.
86. Heath H 3rd, Hodgson SF, Kennedy MA: Primary hyperparathyroidism: Influence, morbidity, and potential economic impact in the community. N Engl J Med 1980;302:189-193.
87. Bell NH, Stern PH, Pantzer E, Sinha TK, DeLuca HF: Evidence that increased circulating 1 alpha,25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 1979;64:218-225.
88. Canales BK, Leonard SM, Singh JA, Orzano IM, Zimmermann B, Weiland D, Monga M, Krug HE: Spondyloarthropathy: an independent risk factor for kidney stone. Endourol 2006;20:542-546.
89. Serdar Gozen A, Serkan Kilic A, Aktoz T, Akdere H: Renal anatomical factors for the lower calyceal stone formation. Int Urol Nephrol 2006;38:79-85.
90. Ku JH, Jung JK, Lee JK, Park WH, Shim HB: Risk factors for urinary stone formation in men with spinal cord injury: a 17-year follow-up study. BJU Int 2006;97:790-793.
91. Kleinschmidt K, Mahlmann A, Hautmann R: Intestinal oxalate degrading bacteria decrease urinary oxalate in stone formers. Proceedings of AUA. J Urol 1995;151:425.
92. Griffith DP, Osborne CA: Infection (urease) stones. Miner Electrol Metab 1987;13:278-285.
93. Ciftcioglu N, Bjorklund M, Kuorikoski K: Nanobacteria: an infectious cause for kidney stone formation. Kidney Int 1999;56:1893-1898.
94. Mohkam M, Karimi A, Gharib A, Daneshmand H, Khatami A, Ghojevand N, Sharifian M: Ceftriaxone associated nephrolithiasis: a prospective study in 284 children. Pediatr Nephrol 2007;22:690-694.
95. Servais A, Daudon M, Knelbelman B: Drug-induced renal calculi. Ann Urol 200;40:57-68.
96. Welch BJ, Graybeal D, Moe OW, Maalouf NM, Sakhaee K: Biochemical and stone-risk profiles with topiramate treatment. Am J Kidney Dis 2006;48:555-563.
97. Menon M, Resnick MI: Urinary lithiasis: etiology, diagnoses, and medical management; in Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds): Campbell's Urology, ed 8. Philadelphia, Saunders, 2002, pp 3229-3305.
98. Sutherland SE, Reigle MD, Seftel AD, Resnick MI: Protease inhibitors and urolithiasis. J Urol 1997;158:31-33.
99. May M, Kubenz K, Seehafer M, Wolter M, Hoschke B: Silica containing urinary stones - clinical issue to keep in mind. Urologe A 2005;44:68-72.
100. Jackson RD LaCroix AZ, Gass M, et al; Women's Health Initiative Investigation: Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-683.
101. Vainder M, Kelly J: Renal tubular dysfunction secondary to jejunoileal bypass. JAMA 1976;235;1257-1258.
102. Durrani O, Morrisroe S, Jackman S, Averch T: Analysis of stone disease in morbidly obese patients undergoing gastric bypass surgery. J Endourol 2006;20:749-752.